Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jul 12, 2024 11:43am
Re: Strategic acquisitions
Of course gagnon would be on the lookout for new acquistions, like the one he did with Juvenite, took a company that had hundred of thousands in sales and ran that down to less than $30,000 in sales
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 12, 2024 8:34am
Strategic acquisitions
Gilles, "constantly looking for strategic growth opportunities.” June 2024 Perplexity Ai on potential strategic acquisitions: Some strategic acquisitions
...more
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource
posted Sep 19, 2024 9:00am by
Northstar Gold Corp.
-
|
The MOU grants Hunan Nonferrous the opportunity to explore and develop a near-surface NI43-101 gold mineral resource at Northstar’s 100%-owned Miller Copper-Gold Property, located 18 kilometers southeast of Kirkland Lake, Ontario. This will be achieved by diamond drilling up to 10,000 meters, allowing Hunan Nonferrous to earn a negotiated interest in the resultant NI43-101 gold resource. ...read more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 12, 2024 8:27am
It took
It took six months to complete the merger... 1 1/2 months to get in the saddle sfter the completion of the merger... Next week the new story begins. Ronald W. Miller: “With the successful
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 12, 2024 7:24am
Major inflection point?
From biotech bear market to biotech bull market where early-stage biotech assets are once again valued above cash instead of below cash? The merger with AEZS could have had epic timing. The S&P
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 11, 2024 10:06pm
Can Dr. Tardif attract global media attention?
Perplexity Ai: Yes, Dr. Jean-Claude Tardif has the potential to attract significant global media attention due to his exceptional achievements and contributions to cardiology research
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 11, 2024 9:55pm
COVID: ‘Visionary’ study finds inflammation years later
Long Covid study: Via imaging, virus found years post-infection (statnews.com)
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 11, 2024 9:35pm
Avenanthramide pill
Gilles said it was avenanthramide's potential that attracted him to CZO originally. A CZO news release said the avenanthramide pill could be CZO's biggest product. Do we have a highly
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 11, 2024 7:34pm
See what comes next?
"...we believe we are poised to significantly propel the Company into its next phase of growth and unlock value as a diversified biopharmaceutical company,” stated Gilles
...more
(6)
•••
User2020
X
View Profile
View Bullboard History
Post by
User2020
on Jul 11, 2024 2:26pm
Oats, please check you messages.
Please check you messages.
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 11, 2024 10:18am
Soft inflation
US inflation came in softer than expected today and the S&P Bitech ETF is now up 26% since two weeks prior to the announcement of the merger between AEZS and CZO. Only about two weeks in the last
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 11, 2024 9:13am
RE:RE:Licensing deal
That could be an interesting bonus for a licensing deal if AEZS's diagnostic was approved for pediatric and adult use and as a potential standalone. And if there was a longer term path to improve
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jul 11, 2024 8:26am
RE:AEZS's Macimorelin and PGX
We've never heard the company say anything about it and I don't know if there is anything to it. It could be Ai hallucinations but this is what an Ai program is saying... --
...more
(113)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jul 10, 2024 11:54pm
AEZS's Macimorelin and PGX
Here is how Aeterna Zentaris' knowledge of macimorelin could be used in combination with Ceapro's PGX technology: Enhanced Diagnostic Accuracy for Growth Hormone Deficiency: Macimorelin
...more
(167)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Post by
Hopeforthebest
on Jul 10, 2024 7:21pm
Re: NoShowRonnie
Proph, there is a saying in business and one that applies here, "What have you done for me lately" well Lately NoShowRonnie has done absolutely nothing except on a couple occasions he
...more
(1996)
•••
Ciao
X
View Profile
View Bullboard History
Comment by
Ciao
on Jul 10, 2024 7:15pm
RE:RE:Keep going.....
That appears to be the m.o. No stopping them unless OATs decides to. Those concessions that he asked for pre-merger did not pan out. It shows how he was used for the new grift. New shareholders
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
EnviroGold Global Announces Appointment of Chief Operating Officer
Mining Player Sells Off Promising Project for Millions – Here's Where the Cash is Headed